ANCHOR LEAD: FDA HAS RECENTLY APPROVED A NEW AGENT FOR USE AGAINST BREAST CANCER, ELIZABETH TRACEY REPORTS
Breast cancer is a complicated disease, with a host of receptors and genetic markers involved, all of which impact on treatment. Now the FDA has approved a drug that helps prevent new blood vessels from forming called Avastin for use in people with breast cancer. Ben Park, a breast cancer expert at Johns Hopkins, is hopeful about its use.
PARK: Now we have a little bit more confidence saying, okay, maybe it won’t have a benefit for overall survival but it has progression free survival benefits and if we apply it in the adjuvant setting, meaning after a woman gets her surgery she has no evidence of metastatic disease but we suspect she could have micrometastatic disease so we’ll give her chemotherapy, hormonal therapy, and now we have this new drug, Avastin. You know, its another weapon in our armamentarium against breast cancer and hopefully it will make a difference as far as prolonging women’s lives and curing them. :29
Park says women with breast cancer must consult their oncologist to see if Avastin will likely be helpful. I’m Elizabeth Tracey reporting.